Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs
(MDR1) gene expressed in tumor cells and also in several normal tissues, such as intestine, liver, kidney, blood-brain barrier, spinal cord, and placenta. P-gp has been identified in mice, rat, bovine, monkey, rodents, and human beings and has been receiving a particular clinical relevance because t...
Main Authors: | Linardi Renata Lehn, Natalini Cláudio Corrêa |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade Federal de Santa Maria
2006-01-01
|
Series: | Ciência Rural |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782006000100056 |
Similar Items
-
Identification of multi-drug resistance gene (MDR1) in equine ileum
by: Cláudio Corrêa Natalini, et al.
Published: (2006-02-01) -
Multi-drug resistance gene (MDR1) and opioid analgesia in horses
by: Cláudio Corrêa Natalini, et al.
Published: (2006-02-01) -
Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
by: Johannes Matthaei, et al.
Published: (2016-11-01) -
Targeting MDR1-P-glycoprotein (MDR1-Pgp) in immunochemotherapy of acute myeloid leukemia (AML)
by: Maurizio Cianfriglia
Published: (2013-06-01) -
The biology of MDR1-P-glycoprotein (MDR1-Pgp) in designing functional antibody drug conjugates (ADCs): the experience of gemtuzumab ozogamicin
by: Maurizio Cianfriglia
Published: (2013-06-01)